News und Analysen
Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period
Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act
Quidel to Host Virtual Investor Day on November 12, 2020
Quidel Corporation (NASDAQ:QDEL), provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will host its Quidel
Puma Biotechnology to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of
Digitale Führungskräfte von Almirall und Merck KGaA, Darmstadt, Deutschland als Hauptredner auf dem Veeva-Online-Gipfel in Europa
Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Dr. Francesca Domenech Wuttke, Chief Digital Officer bei Almirall, und Alessandro de Luca, CIO des Gesundheitswesens bei Merck KGaA, Darmstadt
Lixoft Expands MonolixSuite™ in Version 2020R1
Lixoft, a Simulations Plus company (Nasdaq: SLP), a leading provider of population PKPD modeling solutions for pharmacometricians and biostatisticians, today announced that it has released version
Dexcom to Host Investor Day on December 9, 2020
DexCom, Inc. (NASDAQ:DXCM) announced today that it will host an Investor Day on December 9, from 8:30 AM until approximately 11:30 AM Pacific Standard Time (11:30 AM – 2:30 PM Eastern). The event
Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe
Veeva Systems (NYSE: VEEV) today announced that Dr. Francesca Domenech Wuttke, chief digital officer at Almirall, and Alessandro de Luca, CIO of healthcare at Merck KGaA, Darmstadt, Germany are
GenSight Biologics Reports Validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency
Regulatory News:
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies
VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005955/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Sensorion Announces Attendance and a Presentation at Upcoming Conferences
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Novocure Prices $500 Million 0% Convertible Senior Notes Private Placement
Novocure (NASDAQ:NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced the pricing of $500 million aggregate principal amount
Aurinia Announces Outcome of AUDREY™ Clinical Trial in Dry Eye Syndrome
Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company, today announced topline data from the Phase 2/3 AUDREY™ clinical
Premier, Inc. Reports Fiscal 2021 First-Quarter Results
Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 first quarter ended September 30, 2020.
All results presented in this press release reflect continuing
Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and
Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System
Waters Corporation (NYSE:WAT) today introduced the new RADIAN™ ASAP™ System, a novel direct mass detector engineered for non-mass spectrometry (MS) experts to conduct fast and accurate analyses of
Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
Novocure (NASDAQ: NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced its intention to offer $500 million aggregate
FDA Bronchitol Approval to Generate Cash Flows for Pharmaxis
It is the gold standard of success in biotech, but not many Australian companies can boast it – approval from the United States Food & Drug Administration (FDA) of a medicine you have researched
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the “FTC”) accepted a proposed consent order, which concludes the FTC’s review of the
ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
Antibe Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock Exchange
Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, is pleased to
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020.
Third quarter 2020 results reflect strong sequential growth:
-
Revenue of $794
PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling
PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer® New Coronavirus
Xencor to Host Third Quarter 2020 Financial Results Webcast and Conference Call on November 5, 2020
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced that it will
Acadia Healthcare Reports Third Quarter 2020 Results
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the quarter ended September 30, 2020, and provided guidance for the fourth quarter of 2020.
The Company